Removal of “Black Box” Warnings on Hormone Therapy Medications

The U.S. Food and Drug Administration will remove “black box” warnings on many hormone therapy medications used for symptoms of menopause and perimenopause. This change is expected to encourage more women to seek treatment. According to FDA Commissioner, the change ends a decades-long “fear machine” and the demonization of menopausal hormone therapy is “an American tragedy.”

Benefits of Hormone Replacement Therapy

Studies show that menopausal hormone therapy can reduce the risk of heart attacks, the leading cause of death in women. The benefits of hormone replacement therapy also include reducing the risk of cognitive decline or Alzheimer’s disease and preventing osteoporosis, a major factor in hip fractures. Hormone therapy can help relieve menopause symptoms, which can be debilitating and cause both mental and physical distress.

Previous Research and Criticisms

The “black box” warnings were based on flawed research on HRT from over 20 years ago. The Women’s Health Initiative study in 2002 overstated the risks of breast cancer because the data focused on older women. Recent studies have shown that the benefits outweigh the risks for many women when hormone therapy is used in the early years of menopause, before age 60.

What Studies Now Say

Over the past two decades, breast cancer fears led doctors to discourage millions of women from receiving hormone therapy. However, no clinical trial has ever shown that hormone therapy increases a woman’s risk of dying from breast cancer. Starting hormone replacement therapy as soon as a woman’s body stops producing estrogen can help prevent bone loss and reduce the risk of osteoporosis.

Non-Hormonal Therapy Treatments

Although hormone therapy is the most effective treatment for hot flashes and night sweats, it is not suitable for everyone, especially women with a history of breast cancer. The FDA has approved new, non-hormonal options that directly target the brain pathways involved in controlling body temperature.

Medical Training and Research

Menopause has been neglected in medical training, and research funding has been limited in the past. However, with more women in the field, this is starting to change. Medical students are now being taught about menopause, and the importance of providing adequate treatment and care for women experiencing menopause symptoms.